Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzena Ingram

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|June 20, 2020
A Quantitative Study of US FDA Inspection Data for Drug Manufacturing SitesAjay Babu Pazhayattil, Marzena Ingram, Naheed Sayeed
PDA Journal of Pharmaceutical Science and Technology|April 18, 2026
Application of Stage 3a Heightened Monitoring to Close Process Knowledge Gaps of Legacy Injectable Products: A Commercial Scale Case StudyAjay Babu Pazhayattil, Avinash Joshi, Marzena Ingram
PDA Journal of Pharmaceutical Science and Technology|February 16, 2020
A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle StagesAjay Babu Pazhayattil, Naheed Sayeed-Desta, Shu Chen, et al.
AAPS Pharmscitech|September 10, 2015
Stage 2 Process Performance Qualification (PPQ): a Scientific Approach to Determine the Number of PPQ BatchesAjay Pazhayattil, Daniel Alsmeyer, Shu Chen, et al.
AAPS Pharmscitech|October 8, 2016
Assessment Methodology for Process Validation Lifecycle Stage 3ANaheed Sayeed-Desta, Ajay Babu Pazhayattil, Jordan Collins, et al.
PDA Journal of Pharmaceutical Science and Technology|November 24, 2025
Variability Assessment Methods for Lyophilized Drug Product, A Case StudyAjay Babu Pazhayattil, Marzena Ingram, Prasanna Sagar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|June 20, 2020
A Quantitative Study of US FDA Inspection Data for Drug Manufacturing SitesAjay Babu Pazhayattil, Marzena Ingram, Naheed Sayeed
PDA Journal of Pharmaceutical Science and Technology|April 18, 2026
Application of Stage 3a Heightened Monitoring to Close Process Knowledge Gaps of Legacy Injectable Products: A Commercial Scale Case StudyAjay Babu Pazhayattil, Avinash Joshi, Marzena Ingram
PDA Journal of Pharmaceutical Science and Technology|February 16, 2020
A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle StagesAjay Babu Pazhayattil, Naheed Sayeed-Desta, Shu Chen, et al.
AAPS Pharmscitech|September 10, 2015
Stage 2 Process Performance Qualification (PPQ): a Scientific Approach to Determine the Number of PPQ BatchesAjay Pazhayattil, Daniel Alsmeyer, Shu Chen, et al.
AAPS Pharmscitech|October 8, 2016
Assessment Methodology for Process Validation Lifecycle Stage 3ANaheed Sayeed-Desta, Ajay Babu Pazhayattil, Jordan Collins, et al.
PDA Journal of Pharmaceutical Science and Technology|November 24, 2025
Variability Assessment Methods for Lyophilized Drug Product, A Case StudyAjay Babu Pazhayattil, Marzena Ingram, Prasanna Sagar, et al.
Pageof 1